Holen Sie sich die Stockscreener-App
90.10
0.11%
0.10
Handel nachbörslich:
90.15
0.05
+0.06%
Schlusskurs vom Vortag:
$90.00
Offen:
$90.27
24-Stunden-Volumen:
41,999
Relative Volume:
0.37
Marktkapitalisierung:
$N/A
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
+2.04%
1M Leistung:
+5.17%
6M Leistung:
+34.47%
1J Leistung:
+27.82%
1-Tages-Spanne:
$89.41
$91.03
1-Wochen-Bereich:
$89.41
$91.03
52-Wochen-Spanne:
$58.97
$91.03
Ishares U S Pharmaceuticals Etf Stock (IHE) Company Profile
Firmenname
Ishares U S Pharmaceuticals Etf
Sektor
Branche
Telefon
-
Adresse
-
Compare IHE vs VTI, SPY, IVV, VB, QQQ
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
IHE
Ishares U S Pharmaceuticals Etf
|
90.10 | 0 | 0 | 0 | 0 | 0.00 |
|
VTI
Vanguard Total Stock Market Etf
|
336.01 | 417.53B | 0 | 0 | 0 | 0.00 |
|
SPY
State Street Spdr S P 500 Etf Trust
|
681.27 | 372.57B | 0 | 0 | 0 | 0.00 |
|
IVV
Ishares Core S P 500 Etf
|
684.33 | 253.41B | 0 | 0 | 0 | 0.00 |
|
VB
Vanguard Small Cap Etf
|
272.94 | 160.59B | 0 | 0 | 0 | 0.00 |
|
QQQ
Invesco Qqq Trust Series 1
|
600.64 | 124.43B | 0 | 0 | 0 | 0.00 |
Ishares U S Pharmaceuticals Etf Aktie (IHE) Neueste Nachrichten
U.S. Pharmaceutical Giants Drive ETF Performance with Strong Results - AD HOC NEWS
Is State Street SPDR S&P Pharmaceuticals ETF (XPH) a Strong ETF Right Now? - sharewise.com
UnitedHealth Flags Margin Stress, Pushing Investors Toward Broader Healthcare ETFs - Benzinga
Should You Invest in the VanEck Pharmaceutical ETF (PPH)? - sharewise.com
Should You Invest in the State Street SPDR S&P Pharmaceuticals ETF (XPH)? - sharewise.com
3 Healthcare ETFs to Buy as Flat Medicare Rate Proposal Hits Insurers - TradingView
Where Will Eli Lilly Be in 10 Years? - The Motley Fool
Economist Warns Trump's Full Drug Tariff Will Burden Americans, Not Foreign Companies - intellectia.ai
5 Biggest Pharmaceutical ETFs for Investors in 2026 - Nasdaq
Winners & Losers: The ETF Playbook to Glide Trump's Great Healthcare Plan - The Globe and Mail
Should you invest in the iShares US Pharmaceuticals ETF (IHE)? - MSN
Trump Unveils 'Great Healthcare Plan,' Takes Aim At PBM 'Kickbacks' - Benzinga
Is Invesco Pharmaceuticals ETF (PJP) a Strong ETF Right Now? - sharewise.com
Should You Invest in the iShares U.S. Pharmaceuticals ETF (IHE)? - Yahoo Finance
4 Top-Ranked ETF Areas That Beat the Market in 2025 - The Globe and Mail
PPH: The Big Pharma ETF (NASDAQ:PPH) - Seeking Alpha
Bet on These Top-Ranked Healthcare ETFs Before 2025 Ends - The Globe and Mail
Should You Invest in the Invesco Pharmaceuticals ETF (PJP)? - sharewise.com
Aug Opening: Is iShares U.S. Pharmaceutical ETF stock a top pick for value investorsPortfolio Update Report & Free Growth Oriented Trading Recommendations - Улправда
Why Health Care ETFs Aren't Panicking Over Big Pharma's Price Cuts - Benzinga
Pharma's $370B Bet on America: The ETF Plays for 2026 - The Globe and Mail
iShares Dow Jones US Pharmaceuticals ETF (IHE) Stock News & Articles - 24/7 Wall St.
Short bets on S&P 500 healthcare sector rises to 2.12% in November; MRNA stays most shorted stock - MSN
3 dividend ETFs to buy and hold for life if the market crashes - MSN
3 Dividend ETFs to Buy and Hold for Life if the Market Crashes - AOL.com
Pharma ETFs to Gain From Landmark UK-US Zero-Tariff Deal - sharewise.com
iShares U.S. Pharmaceuticals ETF $IHE Shares Sold by Brown Advisory Inc. - Defense World
The pharmaceutical sector is surging. Here's 1 stock every investor should have on their radar. - MSN
The Pharmaceutical Sector Is Surging. Here's 1 Stock Every Investor Should Have on Their Radar. - The Globe and Mail
Tema’s Oncology ETF (CANC) Surpasses $100m in Assets Amidst Strong 2025 Performance - PharmiWeb.com
Pharma ETFs: Your Key to Diversification in the Pharmaceutical Sector - Investing News Network
IHE: Pharma Powerhouse ETF Despite High Fees And Valuation (NYSEARCA:IHE) - Seeking Alpha
Novo Nordisk's Stock Slump Shows The GLP‑1 Trade's Side Effect: ETF Concentration Risk - Benzinga
Eli Lilly Hits $1 Trillion Milestone: ETFs to Invest in - TradingView
Eli Lilly Supremacy: How One Stock Is Dictating Performance Across Pharma ETFs - Benzinga
Finanzdaten der Ishares U S Pharmaceuticals Etf-Aktie (IHE)
Es liegen keine Finanzdaten für Ishares U S Pharmaceuticals Etf (IHE) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
1.07%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):